Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McHutchison

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The American Journal of Medicine|February 1, 2000
Hepatitis C therapy in treatment-naïve patientsJ McHutchison
Expert Opinion on Pharmacotherapy|October 5, 2001
Peginterferon alpha-2b: a new approach to improving response in hepatitis C patientsK Patel, J McHutchison
Journal of Viral Hepatitis|March 28, 2008
Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis CJ McHutchison, M Sulkowski
Clinics in Laboratory Medicine|October 8, 1997
Autoimmune liver diseasesD J Bylund, J McHutchison
Journal of Virological Methods|July 14, 2000
Analysis of the viability of freezer stored serum samples for hepatitis C virus RNA analysis by the SUPERQUANT method: results of a 16 year retrospective studyP Schmid, M Tong, A Conrad, et al.
Hepatology (Baltimore, Md.)|December 29, 1999
Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project GroupT Poynard, J McHutchison, Z Goodman, et al.
Journal of Hepatology|July 4, 2001
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis cT Poynard, V Ratziu, F Charlotte, et al.
Journal of Hepatology|October 9, 1998
Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection?J McHutchison, L Blatt, A Sedghi-Vaziri, et al.
Transplantation|March 1, 1993
Systemic versus nonsystemic reperfusion of the transplanted liverJ J Brems, H Takiff, J McHutchison, et al.
Hepatology (Baltimore, Md.)|October 26, 2000
Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis CT Poynard, J McHutchison, G L Davis, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|February 1, 2000
Hepatitis C therapy in treatment-naïve patientsJ McHutchison
Expert Opinion on Pharmacotherapy|October 5, 2001
Peginterferon alpha-2b: a new approach to improving response in hepatitis C patientsK Patel, J McHutchison
Journal of Viral Hepatitis|March 28, 2008
Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis CJ McHutchison, M Sulkowski
Clinics in Laboratory Medicine|October 8, 1997
Autoimmune liver diseasesD J Bylund, J McHutchison
Journal of Virological Methods|July 14, 2000
Analysis of the viability of freezer stored serum samples for hepatitis C virus RNA analysis by the SUPERQUANT method: results of a 16 year retrospective studyP Schmid, M Tong, A Conrad, et al.
Hepatology (Baltimore, Md.)|December 29, 1999
Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project GroupT Poynard, J McHutchison, Z Goodman, et al.
Journal of Hepatology|July 4, 2001
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis cT Poynard, V Ratziu, F Charlotte, et al.
Journal of Hepatology|October 9, 1998
Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection?J McHutchison, L Blatt, A Sedghi-Vaziri, et al.
Transplantation|March 1, 1993
Systemic versus nonsystemic reperfusion of the transplanted liverJ J Brems, H Takiff, J McHutchison, et al.
Hepatology (Baltimore, Md.)|October 26, 2000
Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis CT Poynard, J McHutchison, G L Davis, et al.
Pageof 2